top of page

De-ESCALaTE-HPV study shows unexpected results!

Updated: Aug 8, 2019

Our De-ESCALaTE HPV study, published recently in the Lancet, showed the cisplatin was more effective than cetuximab when combined with radiotherapy in the treatment of HPV-associated throat (oropharyngeal) cancer. So cisplatin remains the standard of care for these patients.

For the full article, please see:

51 views0 comments


bottom of page